| Authors: |
Singh SK; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Plieskatt J; PATH's Malaria Vaccine Initiative, Washington, WA, USA., Chourasia BK; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Singh V; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Bengtsson KL; Novavax AB, Uppsala, Sweden., Reimer JM; Novavax AB, Uppsala, Sweden., van Daalen RC; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Teelen K; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., van de Vegte-Bolmer M; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., van Gemert GJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Jore MM; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands. Matthijs.jore@radboudumc.nl., Theisen M; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark. mth@ssi.dk.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. mth@ssi.dk. |
